Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2017, Article ID 9601735, 6 pages
https://doi.org/10.1155/2017/9601735
Research Article

Fine Needle Aspiration of Thyroid Nodules Using the Bethesda System for Reporting Thyroid Cytopathology: An Institutional Experience in a Rural Setting

1Ohio University-Heritage College of Osteopathic Medicine, Athens, OH 45701, USA
2Department of Specialty Medicine, Athens, OH 45701, USA
3The Diabetes Institute at Ohio University, Athens, OH 45701, USA

Correspondence should be addressed to Aili Guo; ude.oiho@aoug

Received 3 October 2016; Revised 14 December 2016; Accepted 4 January 2017; Published 9 February 2017

Academic Editor: Diego Russo

Copyright © 2017 Aili Guo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Gharib and E. Papini, “Thyroid nodules: clinical importance, assessment, and treatment,” Endocrinology and Metabolism Clinics of North America, vol. 36, no. 3, pp. 707–735, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. D. S. Dean and H. Gharib, “Epidemiology of thyroid nodules,” Best Practice Research Clinical Endocrinology Metabolism, vol. 22, no. 6, pp. 901–911, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. H. Gharib, E. Papini, R. Paschke et al., “AACE/AME/ETA Task Force on Thyroid Nodules,” Endocrine Practice, vol. 16, Supplement 1, pp. 1–43, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. D. S. Cooper, G. M. Doherty, B. R. Haugen et al., “Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer,” Thyroid, vol. 19, no. 11, pp. 1167–1214, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. L. Hegedus, “Clinical practice. The thyroid nodule,” New England Journal of Medicine, vol. 351, no. 17, pp. 1764–1771, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. S. J. Mandel, “A 64-year-old woman with a thyroid nodule,” Journal of American Medical Association, vol. 292, no. 21, pp. 2632–2264, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. B. R. Haugen, E. K. Alexander, K. C. Bible et al., “2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer,” Thyroid, vol. 26, no. 1, pp. 1–133, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. E. S. Cibas and S. Z. Ali, “The Bethesda system for reporting thyroid cytopathology,” Thyroid, vol. 19, no. 11, pp. 1159–1165, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Bongiovanni, A. Spitale, W. C. Faquin, L. Mazzucchelli, and Z. W. Baloch, “The Bethesda system for reporting thyroid cytopathology: a meta-analysis,” Acta Cytologica, vol. 56, no. 4, pp. 333–339, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. R. Nayar and M. Ivanovic, “The indeterminate thyroid fine-needle aspiration: experience from an academic center using terminology similar to that proposed in the 2007 National Cancer Institute Thyroid Fine Needle Aspiration State of the Science Conference,” Cancer, vol. 117, no. 3, pp. 195–202, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. V. Jo, E. B. Stelo, S. M. Dustin, and K. Z. Hanley, “Malignancy risk for fine-needle aspiration of thyroid lesions according to the Bethesda system for reporting thyroid cytopathology,” American Journal of Clinical Pathology, vol. 134, no. 3, pp. 450–456, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. P. Arul, C. Akshatha, and S. Masilamani, “A study of malignancy rates in different diagnostic categories of the Bethesda system for reporting thyroid cytopathology: an institutional experience,” Biomedical Journal, vol. 38, no. 6, pp. 517–522, 2015. View at Publisher · View at Google Scholar
  13. E. A. Krauss, M. Mahon, J. M. Fede, and L. Zhang, “Application of the Bethesda classification for thyroid fine-needle aspiration: institutional experience and meta-analysis,” Archives of Pathology & Laboratory Medicine, vol. 140, no. 10, pp. 1121–1131, 2016. View at Publisher · View at Google Scholar
  14. Y. S. Choi, S. W. Hong, J. Y. Kwak, H. J. Moon, and E. K. Kim, “Clinical and ultrasonographic findings affecting nondiagnostic results upon the second fine needle aspiration for thyroid nodules,” Annals of Surgical Oncology, vol. 19, no. 7, pp. 2304–2309, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. N. A. Bakshi, I. Mansoor, and B. A. Jones, “Analysis of inconclusive fine-needle aspiration of thyroid follicular lesions,” Endocrine Pathology, vol. 14, no. 2, pp. 167–175, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. V. Y. Jo, P. A. Vanderlaan, E. Marqusee, and J. F. Krane, “Repeatedly nondiagnostic thyroid fine-needle aspirations do not modify malignancy risk,” Acta Cytologica, vol. 55, no. 6, pp. 539–543, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. N. Khati, T. Adamson, K. S. Johnson, and M. C. Hill, “Ultrasound of the thyroid and parathyroid glands,” Ultrasound Quarterly, vol. 19, no. 4, pp. 162–176, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Erbil, A. Salmaslıoğlu, E. Kabul et al., “Use of preoperative parathyroid fine-needle aspiration and parathormone assay in the primary hyperparathyroidism with concomitant thyroid nodules,” American Journal of Surgery, vol. 193, no. 6, pp. 665–671, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. R. Abdelghani, S. Noureldine, A. Abbas, K. Moroz, and E. Kandil, “The diagnostic value of parathyroid hormone washout after fine-needle aspiration of suspicious cervical lesions in patients with hyperparathyroidism,” Laryngoscope, vol. 123, no. 5, pp. 1310–1313, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. V. Bernet, K. H. Hupart, S. Parangi, and K. A. Woeber, “AACE/ACE disease state commentary: molecular diagnostic testing of thyroid nodules with indeterminate cytopathology,” Endocrine Practice, vol. 20, no. 4, pp. 360–363, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. E. K. Alexander, G. C. Kennedy, Z. W. Baloch et al., “Preoperative diagnosis of benign thyroid nodules with indeterminate cytology,” New England Journal of Medicine, vol. 367, no. 8, pp. 705–715, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. R. L. Ferris, Z. Baloch, V. Bernet et al., “American Thyroid Association statement on surgical application of molecular profiling for thyroid nodules: current impact on perioperative decision making,” Thyroid, vol. 25, no. 7, pp. 760–768, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. R. Gerhard and S. L. Boerner, “The value of second opinion in thyroid cytology,” Cancer Cytopathology, vol. 122, no. 8, pp. 611–619, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. E. S. Cibas, Z. W. Baloch, G. Fellegara et al., “A prospective assessment defining the limitations of thyroid nodule pathologic evaluation,” Annals of Internal Medicine, vol. 159, no. 5, pp. 325–332, 2013. View at Publisher · View at Google Scholar · View at Scopus